Statins Promote Cardiac Infarct Healing by Modulating Endothelial Barrier Function Revealed by Contrast-Enhanced

Geert J Leenders1, Mirjam B Smeets1, Maaike van den Boomen1

  • 1From the Department of Biomedical Engineering, Biomedical NMR, Eindhoven University of Technology, The Netherlands (G.J.L., M.v.d.B., M.N., G.J.S., J.J.P., K.N., K.V.); Laboratory of Experimental Cardiology (M.B.S.) and Department of Cardiology (F.A.), University Medical Center Utrecht, The Netherlands; Department Precision and Decentralized Diagnostics, Philips Research Eindhoven, The Netherlands (M.B., D.v.S.); Biomedical Engineering and Physics, Academic Medical Center, Amsterdam, The Netherlands (G.J.S.); and Department of Cardiology, St. Antonius Hospital Nieuwegein, The Netherlands (F.A.).

Insights

Statins improve heart attack healing by reducing blood vessel leakage and inflammatory cell entry into damaged heart tissue. This enhances recovery and prevents further heart damage after myocardial infarction (MI).

Area of Science:

  • Cardiovascular Research
  • Endothelial Biology
  • Pharmacology

Background:

  • Endothelial barrier function is critical for wound healing and is impaired in atherosclerosis preceding myocardial infarction (MI).
  • Statins are known to modulate endothelial function beyond lipid-lowering effects.

Purpose of the Study:

  • To noninvasively assess the effect of statins on endothelial permeability during the inflammatory and reparative phases of post-MI healing.
  • To correlate endothelial permeability with left ventricular (LV) remodeling and functional outcomes.

Main Methods:

  • Contrast-enhanced cardiac magnetic resonance imaging (MRI) for noninvasive permeability mapping in mouse models (C57BL/6, ApoE-/-) with and without statin treatment.
  • Correlation of MRI findings with LV volumetry, histology, flow cytometry, and gene expression (Vegfa, Angpt1) in infarct regions.

Main Results:

  • Atherosclerotic (ApoE-/-) mice exhibited increased infarct vascular permeability compared to controls, predicting greater LV dilation.
  • Statin treatment significantly reduced infarct vascular permeability in ApoE-/- mice, indicating improved endothelial barrier function.
  • Statins normalized the unbalanced Vegfa/Angpt1 expression ratio and reduced inflammatory leukocyte infiltration (CD45+, LY6Chi monocytes) in the infarct zone.

Conclusions:

  • Statins effectively lower vascular permeability in the infarcted myocardium, thereby reducing the influx of detrimental inflammatory leukocytes.
  • Improved endothelial barrier function and reduced inflammation mediated by statins contribute to better left ventricular outcomes post-MI.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
313
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
225
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
942